Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US-Reference-Cited by-同舟云学术

Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US

Published:2016-01-13 Issue:4 Volume:32 Page:669-680
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Perez-Nieves Magaly¹,Kabul Samaneh¹,Desai Urvi²,Ivanova Jasmina I.³,Kirson Noam Y.²,Cummings Alice Kate²,Birnbaum Howard G.²,Duan Ran¹,Cao Dachuang¹,Hadjiyianni Irene⁴

Affiliation:

1. Eli Lilly and Company, Indianapolis, IN, USA;

2. Analysis Group Inc., Boston, MA, USA;

3. Analysis Group Inc., New York, NY, USA;

4. Lilly Deutschland GmbH, Bad Homburg, Germany

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/03007995.2015.1135789

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological and Benefit-Risk Profile of Once-Weekly Basal Insulin Administration (Icodec): Addressing Patients’ Unmet Needs and Exploring Future Applications;Journal of Clinical Medicine;2024-04-05

2. Greater persistence and adherence to basal insulin therapy is associated with lower healthcare utilization and medical costs in patients with type 2 diabetes: a retrospective database analysis;BMJ Open Diabetes Research & Care;2024-03

3. The Basis for Weekly Insulin Therapy: Evolving Evidence With Insulin Icodec and Insulin Efsitora Alfa;Endocrine Reviews;2024-01-16

4. Exploring the Experiences and Perspectives of Insulin Therapy in Type 2 Diabetes via Web-Based UK Diabetes Health Forums: Qualitative Thematic Analysis of Threads;JMIR Diabetes;2022-10-05

5. Where to Initiate Basal Insulin Therapy: Inpatient or Outpatient Department? Real-World Observation in China;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2022-10